Vernetzung in Europa

EU-Verbundprojekte der Universität Bonn

Zur Forschung an der Universität Bonn gehört die Kooperation mit exzellenten internationalen Partnern, weshalb die Beteiligung am EU-Forschungsrahmenprogramm Horizon Europe von großer Bedeutung ist.

Verbundprojekte (Koordination)

Sie finden hier eine Übersicht über die EU-Verbundprojekte, die von Wissenschaftler*innen der Universität Bonn koordiniert werden.

Macustar
© colourbox

EU-Verbundprojekte, die von der Universität Bonn koordiniert werden

Koordinator

Prof. Dr. Jan Börner
Institut für Lebensmittel- und Ressourcenökonomik (ILR)
Nussallee 19
53115 Bonn

Abstract

CLEVER identifies new leverage points for sustainable transformation informed by a novel holistic approach to quantify biodiversity and other impacts of trade in major raw and processed non-food biomass value chains. In line with Pillars 3 & 4 of the EU Biodiversity Strategy 2030, we address all outcomes of this topic by adopting perspectives at the system and value chain levels. At the system level, we improve our understanding of leakage effects in the non-food biomass trade system informed by quasi-experimental evaluation techniques, quantitative scenario modelling, and policy case studies. At the value chain level, CLEVER engages with key stakeholders (i.e., producers, traders, retailers, civil society, and policy makers) in R&I co-design to identify leverage points for transformative change at corporate and institutional levels. Value chain analyses will produce ‘ecological footprints’ from advanced life cycle analyses and enhance our understanding of actor-specific behavior focusing on trade in soy, timber, wood pulp, and fishmeal/oil between Europe, South America, and Central Africa. Further CLEVER products and tools to influence decision-making at the right level include (1) improved indicators of biodiversity loss to inform business and policy, (2) enhanced features for the global modelling platform GLOBIOM to quantify trade-mediated leakage and SDG interdependencies in biomass value chains, and (3) an
innovation action pool to support public and private decision-makers in choosing governance instruments that effectively enhance biodiversity and promote climate change mitigation and adaptation. Building on prior and ongoing engagement of its members at the science-policy interface and through partnerships with other projects under the destination on biodiversity and ecosystem services, the consortium will leverage CLEVER knowledge and tools to strengthen IPBES and IPCC and enhance science-industry cooperation for sustainable bioeconomic transformation.

Laufzeit

2022 - 2025

Koordinator

Prof. Dr. Dirk Lanzerath
Deutsches Referenzzentrum für Ethik in den Biowissenschaften
Bonner Talweg 57
53113 Bonn

Abstract

The research ethics process is facing increasing challenges at a global level: new and emerging technologies present challenges to ethics reviewers who may be unskilled in the relevant fields; increased internationalisation of research has led to fears of ethics dumping; and there is a lack of standardisation across Europe and the world. A key objective of national and EU research policy is to ensure compliance with the highest standards of research ethics. Given the impact of research on society, in terms of potential to generate innovative solutions to problems, and yet with the associated risk of harm, rigorous ethical research conduct is essential to ensure public trust in the scientific endeavour. iRECS will address these problems in four ways. First, it will scan and map existing needs raised by new and emerging technologies in European and global research ethics communities. Second, it will produce and implement training materials for European and global audiences in research ethics communities. Third, it will conduct and permanently establish training programmes. Fourth, it will propose adaptations to the research ethics process in Europe. Through a unique blend of expertise, global partners and the involvement of European research ethics networks as partners or members of the Stakeholder Advisory Board, iRECS will develop a fresh awareness of research ethics and sustainable, multi-purpose, multi-language interactive training programmes for different users. The project thus extends ENERI and the Embassy of Good Science into a horizontal community of research ethics practitioners, policy makers and other key stakeholders.

Laufzeit

2022 - 2025

Koordinatorin

Prof. Dr. Annette Scheersoi
Fachdidaktik Biologie
Meckenheimer Allee 170
53115 Bonn

Abstract

We are facing complex societal challenges, such as protecting the environment, promoting healthy living and fighting climate change. To address such challenges, citizens must be equipped with the ability to responsibly engage in scientific discussions and decisions. Traditional formal schooling has not been able to achieve this goal: There is a wide-spread lack of scientific knowledge at all level of society and students' interest in science tends to decline within school years. One reason is the decontextualised way in which science is taught. MULTIPLIERS aims to facilitate the transition of schools into innovative and open collectors of new ideas, practices, scientific approaches, able to offer to the communities in which they are embedded a space for open, inclusive and inquiry-based learning on science issues which have an impact on citizens' lives. This will be achieved by establishing multiplayers' partnerships (Open Science Communities, OSCs) involving schools, families, civil society organisations, informal education providers, policy-makers, the media and a vast range of science institutions in six EU countries, very different in terms of geographical and economic situation. OSCs will jointly select socio-scientific issues to be tackled and develop real-life projects to be implemented in schools involving more than 1500 students of all educational levels across six EU countries. Students will interact with a broad spectrum of science professionals and be involved in data collection and decision-making processes. Via open community events, they will then share and rethink their findings and experiences, liaising with families and society, acting as science multipliers. To ensure the results' transferability and uptake, final recommendations, guidelines, and learning materials will be published in an multilingual open webspace; OSCs will be maintained and enlarged after the end of the project to further pursue the MULTIPLIERS open schooling process.

Laufzeit

01.11.2021 - 31.10.2024

Website

Koordinator

Prof. Dr. Frank G. Holz / Prof. Dr. Dr. Robert Finger
Universitäts-Augenklinik Bonn
Universitätsklinikum Bonn
Ernst-Abbe-Straße 2
53127 Bonn

Abstract

People with dry age-related macular degeneration (AMD) gradually lose their central vision, usually in both eyes. It is already a leading cause of blindness worldwide, and as the population ages, the number of cases is likely to rise. There is currently no effective treatment for dry AMD. One barrier to the development of new treatments is the lack of tests capable of determining the effectiveness of treatments under development. Put simply, current tests do not detect all of the sight problems experienced by people with earlier stages of the disease (e.g. intermediate AMD).
The goal of the MACUSTAR project is to develop and validate tests that are capable of accurately detecting subtle changes in the disease over time. The project will follow more than 700 AMD patients over 3 years through tests including state-of-the-art imaging techniques and vision testing, as well as patient-reported outcome measures that capture the impact of the disease on patients’ quality of life. The hope is that these methods will prove capable of detecting changes in the patients’ disease. The team also hopes to shed new light on visual impairment in intermediate AMD and its progression, as well as the risk factors that cause the disease to progress faster in some patients than others.
By developing and validating new methods to study disease progression in dry AMD, the overall goal of MACUSTAR is to help drug development and make clinical trials of potential treatments more efficient.

Laufzeit

01.09.2017 - 31.08.2022

Website


Verbundprojekte (Partner)

Wissenschaftler*innen der Universität Bonn sind darüber hinaus in zahlreichen EU-Verbundprojekten als Partner beteiligt. Informieren Sie sich hier über die verschiedenen Projekte.

SCREEN4CARE.JPG
© screen4care

EU-Verbundprojekte, an denen die Universität Bonn als Partner beteiligt ist

Partner

Prof. Dr. Janbernd Kirschner
Zentrum für Kinderheilkunde
Venusberg-Campus 1
53127 Bonn

Abstract

In the EU alone, roughly 30 million people are affected by one of the more than 6,000 different rare diseases (RDs) of which 72% are genetic and 70% affect children. The path to diagnosis for people suffering from a RD is burdensome, often severely delayed by a diagnostic odyssey. This unacceptable situation does not meet the concept of equity for EU citizens, and requires rapid, structured, and cost-effective corrective actions. The Screen4Care (S4C) consortium will leverage the genomic and digital advent to develop and pilot genetic NBS and AI-guided symptom recognition algorithms, while accounting for all relevant legal, regulatory and ethical considerations. S4C aims to harmonize the results of existing efforts in a horizon scan, by looking at the totality of the available data resources, diagnostic algorithms, and other initiatives with similar ultimate goals. S4C will also provide two digital diagnosis support systems for RD on the basis of features and symptom complexes.

Koordinator

University of Ferrara

Laufzeit

01.10.2021 - 30.09.2026

Website

Partner

Prof. Dr. Christian Henneberger
Institute of Cellular Neurosciences
Venusberg-Campus 1
53127 Bonn

Abstract

Neuroscience has a key role in addressing many of today’s challenges, and brain-centred solutions can benefit society and even spark a new economy in Europe. Pooling the educational and training capacity of eight universities in Europe, the European University of Brain and Technology (NeurotechEU) aims to educate and train the next generation of scientists and scholars. Under the EU-funded NeurotechRI project, the focus will also be on the sharing of infrastructure and resources. Specifically, the project will implement a novel governance organisation for multi-institutional, international and intersectoral research collaboration and innovation. It will also develop joint structures with external stakeholders and foster academia business cooperation. The goal is to support a balanced circulation of knowledge.

Koordinator

Stichting Radboud Universiteit

Laufzeit

01.10.2021 - 30.09.2024

Website

Partner

Prof. Dr. Maren Bennewitz
Computer Science VI - Intelligent Systems and Robotics
Friedrich-Hirzebruch-Allee 8
53115 Bonn

Abstract

The physical reconstruction of shattered artworks is one of the most labour-intensive steps in archaeological research. Dug out from excavation sites are countless ancient artefacts, such as vases, amphoras and frescoes, that are damaged. The EU-funded RePAIR project will facilitate the reconstruction process to bring ancient artworks back to life. Specifically, it will develop an intelligent robotic system that can autonomously process, match and physically assemble large fractured artefacts in a fraction of the time required by humans. This new system will be tested on iconic case studies from the UNESCO World Heritage Site of Pompeii. It will restore two world-renowned frescoes, which are in thousands of broken pieces and currently in storerooms.

Koordinator

Universita Ca'Foscari Venezia

Laufzeit

01.09.2021 - 28.02.2025

Partner

Dr. Melanie Braun
Institute of Crop Science and Resource Conservation
Nussallee 13
53115 Bonn

Abstract

The EU-funded PAPILLONS project will investigate the sustainability of agricultural plastics (AP) in relation to releases and impacts of microplastics and nanoplastics (MNP) in European soils. The initiative will promote knowledge on sources, behaviour and impacts through cross-disciplinary research, bringing together experts from chemistry, materials engineering, agronomy, soil ecology, toxicology and social sciences. PAPILLONS will transform the knowledge generated into guidance for policy-makers, the agricultural sector and world-class industries to promote sustainable farm production systems. Researchers will deliver the first digital European atlas of AP use, management and waste production to estimate sources of MNP in agricultural soils and integrate studies at laboratory, mesocosm and field scales in different parts of Europe.

Laufzeit

01.06.2021 - 31.05.2025

Website

Partner

Prof. Dr. Michael Famulok
Life & Medical Sciences Institute (LIMES)
Gerhard-Domagk-Str. 1
53121 Bonn

Abstract

The EU-funded DESTINATION project aims to create a first-generation RNA-based delivery platform (RNano) for effective delivery of information (mRNA) into cells in vivo. Addressing this challenging goal requires a novel, biocompatible and scalable system to protect the deliverable mRNA from degradation in blood, escape the immune response, and provide high selectivity in cell targeting. The consortium will use AI/machine learning to generate a library of programmable RNano scaffolds for packaged mRNA and RNA aptamers for laser-specific internalisation of RNanos into cells. DESTINATION success could enable novel functions such as the production of a cell's own medicine by replacing the faulty mRNA or engineering cells to fight genetic disorders and cancer.

Koordinator

Sixfold Bioscience LTD

Laufzeit

01.04.2021 - 31.03.2025

Website

Partner

Dr. Fabian Hügging
Physikalisches Institut
Wegelerstr. 8
53115 Bonn

Abstract

Particle physics attracts a global community of more than 10,000 scientists, and Europe’s leadership, with CERN as its major laboratory, is internationally recognised. Discoveries are technology-driven; more performant accelerators require innovative detectors to unfold their scientific potential, driving available or emerging technologies beyond their limits. The role of industry is rapidly increasing, due to the need for highly specialised equipment and due to the scale of the installations, where thousands or millions of components require industrial-scale infrastructure.
AIDAinnova advances the European detector development infrastructures through fostering an intensified co-innovation with industry. Based on the success of the previous EC-funded initiatives AIDA and AIDA-2020, the project as a novel element fully integrates commercial players, 10 industrial companies and 3 RTOs, together with academic institutions into the consortium, which comprises 46 partners from 15 countries. Knowledge transfer will be catalysed through co-innovative work in common detector projects, and it will strengthen the competence and competitiveness of the industrial partners in other markets.
AIDAinnova provides state-of-the-art upgrades of research infrastructure such as test beam and irradiation facilities, and it covers all key technologies for future detectors, following the guidance by the European Particle Physics Strategy Update. The focus is on strategic developments at intermediate technological readiness levels TRL 2-7, where developments are not yet as specific to one particular experiment as in the engineering phase, and it also includes prospective R&D at TRL 1. Therefore, AIDAinnova will unfold synergies by bringing together the expertise from communities aiming at various future projects and maximise the use of resources. Through the large leverage on matching funds from national sources the project leads to enhanced coherence and coordination at a European level.

Laufzeit

01.04.2021 - 31.03.2025

Website6

Partner

Prof. Dr. Markus Noethen
Institut für Humangenetik
Venusberg-Campus 1
53127 Bonn

Abstract

Despite the continuous development of treatments for patients with mental illness, crucial factors such as genetic heterogeneity, low compliance and commonly encountered side effects limit treatment efficacy. In contrast with the widespread practice of selecting medication through trial and error, pharmacogenetic testing enables the evaluation of person-specific factors that make the clinical response and side effects foreseeable. The EU-funded PSY-PGx project is introducing a large-scale non-industry sponsored clinical study in 6 European (related) countries and the US that demonstrates the clinical benefits and the potential of implementing pharmacogenetics for psychiatric patients in existing medical settings.

Koordinator

Universiteit Maastricht

Laufzeit
01.03.2021 - 28.02.2026

Website

Partner

Prof. Dr. Oliver Brüstle
Institute of Reconstuctive Neurobiology
Venusberg-Campus 1
53127 Bonn

Abstract

The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) unites 49 partner organisations and institutions across Europe, including the major European advanced therapies learned societies, with the common goal of providing reliable and accessible information related to cell and gene therapy development to European stakeholders. EuroGCT has two major objectives:

  • To provide patients, people affected by conditions, healthcare professionals and citizens with accurate scientific, legal, ethical and societal information and with engagement opportunities, and thus to support better informed decision-making related to cell and gene-based therapies.
  • To facilitate better decision-making at key points in development of new therapies and thus enable improved product development, by providing the research community and regulatory and healthcare authorities with an information source on the practical steps needed for cell and gene therapy development.

To achieve our aims, EuroGCT will adopt a highly structured system for coordinated management of information related to cell and gene therapy development and, from this, will implement an ambitious programme of online and direct stakeholder information provision and engagement. All outputs will be delivered in 7 European languages, to ensure broad accessibility, and will be rigorously evaluated against measurable objectives throughout the project duration. The proposed consortium comprises leading cell and gene therapy-related organisations and basic and clinical research labs across Europe, including new member states; together with experts in product development, ethical, legal and societal issues, and in evaluating clinical outcomes; patient representatives; and science communicators. It thus is uniquely placed to develop a world-leading cell and gene therapy information resource and to meet the challenge outlined in Topic SC1-HCO-19-2020.

Koordinator

University of Edinburgh

Laufzeit

01.02.2021 - 31.01.2026

Website

Partner

Prof. Dr. Cyrill Stachniss
Institute of Geodesy and Geoinformation
Nussallee 15
53115 Bonn

Abstract

With pressure mounting on healthcare systems worldwide, assistive healthcare robotics is becoming an increasingly attractive option to address current challenges. The EU-funded HARMONY project aims to introduce robust, flexible and safe autonomous mobile manipulation robots for use in human-centred environments by making fundamental contributions to cognitive mechatronic technologies. The end-user partners have identified two areas where the new technology would provide the most benefits: the automation of just-in-time delivery tasks and the automation of hospital bioassay sample flow. HARMONY will demonstrate the new solutions, proving that robotic mobile manipulation systems can indeed meet the growing needs in the healthcare sector and beyond.

Koordinator

ETH Zürich

Laufzeit

01.01.2021 - 30.06.2024

Website

Partner

Prof. Dr. Joachim L. Schultze
DZNE / LIMES-Institut der Universität Bonn
Gemeinsame epigenomische Plattform

Venusberg-Campus 1
Gebäude 99
53127 Bonn

Abstract

Sepsis, the body's extreme response to an existing infection, is a life-threatening medical emergency. Without urgent treatment, sepsis can rapidly lead to tissue damage, organ failure and death. Antibiotics and intensive care units have dramatically improved sepsis treatment, and there is hope that immunotherapy can further improve outcomes. The mission of the EU-funded ImmunoSep project is to design and complete a proof-of-concept clinical trial of personalised immunotherapy in sepsis, and develop a next-generation theranostics platform for future personalised immunotherapy trials in sepsis. Theranostics is a new approach that combines specific targeted therapy based on specific targeted diagnostics. The theranostics platform of the current project will be based on a multidimensional systems biology analysis of omics-based data sets, to identify clinically relevant biomarkers and therapeutic targets for precision medicine.

Koordinator 

Stichting Katholieke Universiteit

Laufzeit 

01.01.2020 - 31.12.2023

Website32

Partner

Prof. Dr. Wolfgang Britz
Institut für Lebensmittel- und Ressourcenökonomik
Nußallee 21
53115 Bonn

Abstract

Trade agreements often fall short of capturing the complexity of agri-food trade policies, mainly in the case of major structural changes. The EU-funded BATModel project aims to address this issue, advancing the assessment of agri-food trade policies. The project will provide a new modular generation of trade models to support the European Commission, policy makers and other stakeholders in their effort to better account for specific issues such as non-tariff measures, geographical indications, zero trade flows, quality differentiation and global value chains. The project will ensure that its solutions have a long-term and lasting impact.

Koordinator

Institut National De Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Laufzeit

01.09.2020 - 31.08.2024

Partnerin

Prof. Ute Vothknecht
Institut für zelluläre und molekulare Botanik
Kirschallee 1
53115 Bonn

Abstract

The potato is one of the most important food crops in the world. However, its vulnerability to environmental stresses raises major concerns about food security. While there is limited knowledge of combined stress-signalling pathways in model plants like Arabidopsis, we have no such knowledge in crops, due to their particular metabolic mechanisms. The EU-funded ADAPT project will study the dynamics of complex signalling and response mechanisms, to identify the molecular mechanisms of adaptation to combined stress in potato. The project will develop new strategies for increased productivity, stability and quality under multiple stress conditions. It will combine molecular biology, stress physiology, systems biology and analytics with engineering and molecular breeding, engaging user-driven agencies for testing and implementation of the project's results.

Koordinator

Universität Wien

Laufzeit

01.07.2020 - 30.06.2024

Website3

Partnerin

Dr. Hajira Jabeen
Institut für Informatik
Endenicher Allee 19a
53115 Bonn

Abstract

The digitalisation of the energy sector enables higher levels of operational excellence with the adoption of disrupting technologies. The EU-funded PLATOON project offers methodology that deploys distributed/edge processing and data analytics technologies for optimised real-time energy system management in a simple way for energy domain experts. The project aims to develop and use the PLATOON reference architecture to build and deploy scalable and replicable energy management solutions that contribute to increased renewable energy consumption, smart grids management, increased energy efficiency and optimised energy asset management.

Koordinator

ENGIE

Laufzeit

01.01.2020 - 31.12.2022

Website 

Partner

Prof. Dr. Joachim L. Schultze
DZNE / LIMES-Institut der Universität Bonn
Gemeinsame epigenomische Plattform

Venusberg-Campus 1
Gebäude 99
53127 Bonn

Abstract

The goal of the EU-funded discovAIR project is to produce the first draft of the Human Lung Cell Atlas platform as a part of the Human Cell Atlas infrastructure. The development of novel therapeutic interventions is hampered by a limited understanding of lung cellular complexity: it is therefore vital to acquire detailed knowledge of lung cells, their interactions, and their organisation into macroscopic tissue architecture, in health and disease. To identify the molecular phenotypes of cells in disease, discovAIR will include lung tissues from patients in the molecular profiling and spatial mapping effort, and will chart cell state transitions from health to disease in the lung cell perturbation map. Project results will be shared with the scientific community and pharmaceutical industry through an open-access data visualisation and exploration platform.

Koordinator

Academisch Ziekenhuis Groningen

Laufzeit

01.01.2020 - 30.06.2022

Website13

Partner

Prof. Dr. Simon Stellmer
Physikalisches Institut 
Nussallee 12
53115 Bonn

Abstract

Building on several joint European efforts and its direct precursor, CLONETS, the EU-funded CLONETS-DS project will design a sustainable, pan-European, ultra-precise time-and-frequency reference system available to the European research community. Specifically, this system will be able to transmit ultra-precise time and frequency information via optical fibres. The project will define the architecture, design the engineering model and strategies, outline roadmaps and elaborate on plans for the integration of the necessary environment into the European landscape. The project’s success will elevate Europe’s research community into a leading position to meet the needs created by technological developments such as cloud computing, the Internet of Things and Industry 4.0.

Koordinator

Geant Vereniging

Laufzeit

01.10.2020 - 30.09.2022

Website6

Partner

Prof. Dr. Franz Josef Hormes
Physikalisches Institut 
Nussallee 12
53115 Bonn

Abstract

SOLARIS is the first synchrotron built in Poland, under the auspices of the Jagiellonian University. The EU-funded Sylinda project will boost the research capacity of SOLARIS. The synchrotron radiation facility will thus be able to upgrade its X-ray absorption spectrometer. This could result in more effective collaborations with industrial partners in the pharmaceutical, biology, chemical and cosmetics sectors. The staff will be reinforced with an industrial liaison officer, a beamline scientist and a grant officer. Special focus will be placed on improving project management, proposal preparation and administration skills. Furthermore, the project will organise a summer school on science management for early-stage researchers. Their active participation in industrial research projects will broaden their views regarding industry innovation and funding opportunities.

Koordinator

Uniwersytet Jagiellonski

Laufzeit

01.01.2021 - 31.12.2023

Partner

Prof. Dr. med. Eicke Latz
Institut für Angeborene Immunität
Sigmund-Freud-Str. 25
53127 Bonn

Abstract

Depression is highly associated with cardiovascular disease (CVD), significantly increasing the risk of CVD development, acute events and mortality, especially in women. As a consequence, it represents a social and economic issue affecting the patient’s life and causing healthcare costs to rise. However, the mechanisms and progression of the disease remain unknown. The EU-funded TO_AITION project works on the hypothesis that immune-metabolic dysregulation due to genetic, lifestyle and environmental risk factors affects immunity mechanisms leading to CVD-associated depression. The project will effectuate basic, preclinical and clinical research applying data-driven strategies to detect and describe immune-metabolic mechanisms responsible for CVD-depression comorbidity, aiming to improve diagnosis and management of the disease.

Koordinator

Idryma Iatroviologikon Ereunon Akademias Athinon

Laufzeit

01.01.2020 - 31.12.2024

Website7

Partner

Prof. Dr. Bernd Weber
Center for Economics and Neuroscience
Nachtigallenweg 86
53127 Bonn

Abstract

Children are attracted to digital technology, but it is not yet clear how digitally mature they are. How is children's behaviour affected by ICT and to what extent? The EU-funded DIGYMATEX project intends to offer evidence-based instruments that can support understanding and estimating ICT effects on children's conduct. The first instrument consists of an advanced and ready for the market Digital Youth Maturity Index (DYMI), a cloud-based open-access instrument. DYMI will contribute in the development of an inclusive taxonomy that will inform stakeholders on the long-term impact of ICT on children and young people's behaviour. The second tool consists of a solution based on the development of the DiGYou programme. Both tools will contribute to a safer and profitable use of ICT.

Koordinator

Aarhus Universitet 

Laufzeit

01.02.2020 - 31.07.2024

Website8

 

Partner

Prof. Dr. Oliver Brüstle
Life & Brain Center
Venusberg-Campus 1
Gebäude 76
53127 Bonn

Abstract

Science has made tremendous progress in understanding the neuronal circuitry of the brain in both health and disease, as well as in terms of its structure and function. Our knowledge of local and distant brain circuitry seen in neurodegenerative diseases, combined with the potential of human embryonic stem cells for cell and tissue regeneration, can advance the treatment of debilitating diseases like Parkinson's and Huntington's. The EU-funded NSC-Reconstruct project is pushing the frontiers in research on stem cells for single cell types. In an ambitious effort, the team plans to reconstruct local networks through the incorporation of numerous cell types, and to restore complex networks and cortical projections, for truly functional and effective repair in complicated conditions like neurodegenerative diseases and stroke.

Koordinator

Universita Degli Studi Di Milano

Laufzeit

01.01.2020 - 31.12.2023

Website

Partner

Prof. Dr. Thomas Heckelei
Institut für Lebensmittel- und Ressourcenökonomik
Nußallee 21
53115 Bonn

Abstract

The European Union’s future Common Agricultural Policy (CAP) plays a pivotal role in developing a sustainable agricultural sector. The future CAP will be more flexible and adaptable to the needs of EU Member States and the individual decision making (IDM) units in the sector. To achieve this Member States develop strategic plans for the CAP that should define measurable objectives and means to achieve them. The EU-funded MIND STEP project will make use of agricultural and biophysical data and include individual decision making (IDM) unity in new and existing policy models for impact assessments. Using agricultural statistics and big datasets, the new IDM models will be estimated and calibrated, drawing on established economic and evolving machine learning techniques.

Koordinator

Stichting Wageningen Research

Laufzeit

01.09.2019 - 31.12.2023

Website18

Partner

Prof. Dr. Christian Borgemeister
Zentrum für Entwicklungsforschung
Genscherallee 3
53113 Bonn

Abstract

The general objective of LEAP4FNSSA is to establish a sustainable structure, or ‘Platform’, for the efficient and coherent implementation of the AU-EU Research and Innovation Partnership as described in the FNSSA Roadmap. Under the aegis of the HLPD and its Bureau, and by building upon related projects such as RINEA, CAAST-Net.
Plus, ProIntensAfrica and LEAP-Agri, LEAP4FNSSA aims to achieve this overall objective through three specific objectives: - Increase the synergies and coherence between actors, research and innovation projects, initiatives and programmes, through the development of institutional alliances and clusters of projects; - Develop a learning environment and a large knowledge base, including monitoring and evaluation activities, creating communication and links between different initiatives to improve STI cooperation; - Establish a long term and sustainable governance and funding mechanism for the Platform. To reach these objectives, LEAP4FNSSA will build on a large consortium of experienced partners and implement a methodology based on 3 principles: long-term impact, relevance of the outputs to the HLPD, and innovative actions. Long-term impact of the CSA relates to its main objective to enable and catalyse the transformation of the existing AU EU FNSSA Partnership into a bi-continental Platform for collaboration, organised along a Knowledge and Management Communication Framework. Outputs relevant to the HLPD will be achieved by connecting and framing activities of all Work Packages on top of the supporting activities specifically requested in the SFS-33-2018. Innovative actions are foreseen to run the Platform efficiently throught e.g. the development of a new approach to information mapping, text and data mining, and testing of multistakeholder alliances at a regional level and the mobilisation of actors to manage research and innovation programming in a 4-steps management cycle.

Koordinator

Centre De Cooperation Internationale En Recherche Agronomique Pour Ledeveloppement - C.I.R.A.D. Epic

Laufzeit

01.11.2018 - 31.10.2022

Website

Partner

Dr. Daniel Neuhoff
Institut für Organischen Landbau
Katzenburgweg 3
D-53115 Bonn

Abstract

"As the world population is continuously increasing, the supply of food with equal accessibility has become a major issue and future challenge. Microbes are unexploited tool to increase food productivity and quality. The objective of SIMBA project is to harness complex soil and marine microbial communities (microbiomes) for the sustainable production of food. SIMBA will focus on two interconnected food chains, i.e. crop production, aquaculture. SIMBA will first launch an in silico phase in order to analyze the further pre-existing microbiome databases and earlier studies, to identify the best microbiome layout capable of supporting food chain quality and productivity. Microbiome-tailored interventions will be specifically developed including soil, plant, fish, aquaculture and food/feed processing towards optimal layout as defined in the modelling step, as follows: i) Identified optimal microbiome consortia will be designed and tested in lab, pot and field trials to improve plant productivity and health; ii) Marine microbiomes will be applied to facilitate sustainable aqua and agriculture; iii) Optimal microbe/microbe consortia will be used to convert raw-materials and residuals to high quality food, feed or finally to energy. In a final intervention step, these interactions will be monitored and tested in field, aqua-culturing, fish feeding and human studies, measuring the impact on microbiome consortia, interactions in association with factors evaluating their efficacy in terms of improving food security, productivity, quality, safety, sustainability, nutritional and health aspects. ""Near to market” microbiome applications for sustainable food systems will be provided thanks to the interdisciplinary and cross-sectional nature of the proposal and the active role of small and medium sized enterprises (SMEs)."

Koordinator

Luonnonvarakeskus

Laufzeit

01.11.2018 - 31.10.2023

Website20

Partner

Prof. Dr. Hartmut Schmieden
Physikalisches Institut
Nussallee 12
53115 Bonn

Abstract

In particle physics, a fundamental mechanism called strong interaction is responsible for strong nuclear force. This is the base of the Standard Model theory. Researchers are seeking to better understand and explain basic topics in this extremely promising field. They do this by conducting experimental and theoretical studies, mainly through particle collisions at low and high energies and calculations. Developments in state-of-the-art detectors are among their goals. The EU-funded STRONG-2020 project supports a close collaboration in a consortium involving 44 groups, 14 EU Member States, CERN and other institutions from numerous countries. It will create new possibilities, both in science and in applied research, for advanced medical and technological applications.

Koordinator

Centre National De La Recherche Scientifique CNRS

Laufzeit

01.06.2019 - 30.11.2023

Website22

Partner

Dr. Kenneth M. Pfarr
Institut für Medizinische Mikrobiologie,
Immunologie und Parasitologie (IMMIP)
Venusberg - Campus 1
Gebäude 63
52127 Bonn

Abstract

Parasitic worms (helminths) are the most common sources of infection in developing countries and represent a greater global disease burden than malaria and tuberculosis. Soil-transmitted helminth infections affect nearly a fourth of the world's population, compromising nutritional status and cognitive processes. Onchocerciasis, also called river blindness, is transmitted by blackflies and causes terrible itching, eye lesions, and often blindness. Thanks to the EU-funded project HELP, an academic and industry collaboration, vaccines for these two infections may be on the horizon. Promising compounds will be fully evaluated in laboratory and clinical trials and this drug pipeline partnership could also streamline vaccine development for numerous neglected diseases.

Koordinator

Schweizerisches Tropen- und Public Health-Institut

Laufzeit

01.09.2019 - 31.08.2024

Website16

Partner

Prof. Dr. med. Lukas Radbruch
Klinik für Palliativmedizin
Venusberg-Campus 1
53127 Bonn

Abstract

The EU-funded PalliativeSedation project is investigating how to better help patients with refractory symptoms near the end of life. It focuses on the clinical, ethical, legal and moral aspects of providing deep sedation to dying patients across Europe. The project will review state-of-the-art refractory symptom management on a national level and current practices and guidelines in five international palliative care centres. Qualitative studies should enrich understanding of palliative sedation practices from the perspective of physicians, nurses and bereaved family members. The project will also conduct a moral case deliberation in 16 clinical centres across Europe to investigate clinical decision making regarding refractory symptoms and proportional palliative sedation. An online course should help clinicians, patients and families to better understand palliative sedation use for refractory symptoms.

Koordinator

Stichting Katholieke Universiteit

Laufzeit

01.01.2019 - 31.12.2023

Partner

Prof. Dr. med. Stefan Aretz
Institut für Humangenetik
Biomedizinisches Zentrum
Venusberg-Campus 1
Gebäude 13
53127 Bonn

Abstract

The main ambitions of the Solve-RD proposal are (i) to solve large numbers of RD, for which a molecular cause is not known yet, by sophisticated combined Omics approaches, and (ii) to improve diagnostics of RD patients through a “genetic knowledge web”. Solve-RD will pursue a clear visionary and integrated “beyond the exome” approach. The entire Solve-RD proposal has been motivated, designed and put together by a core group of four ERNs, but also reaches out to all 24 ERNs. To tackle diseases which are unsolved by applying cutting edge strategies, Solve-RD has thus formed a consortium that comprises (i) leading clinicians, geneticists and translational researchers of these ERNs, (ii) RD research and diagnostic infrastructures, (iii) patient organisations, as well as (iv) leading experts in the field of -omics technologies, bioinformatics and knowledge management. Solve-RD will deliver 7 main implementation steps: (i) Collect Phenotypes, (ii) New phenotype patterns, (iii) Re-analyse exomes / genomes, (iv) Novel molecular strategies, (v) Functional analysis, (iv) Clinical utility and (vii) Towards therapy. For analysis Solve-RD will apply data driven and expert driven approaches. We anticipate to increase diagnostic yield from 19.000 unsolved exomes/genomes by about 3-5%. Cohort specific innovative -omis strategies will be pursued, also addressing cost-effective issues. Analysis of more than 800 patients with highly peculiar (ultra-rare) phenotypes will highly increase the chance to find novel disease genes and novel disease mechanisms. We anticipate to solve more than 2.000 cases. Finding further matching patients will be secured by newly developed matchmaking approaches and by screening using MIPs technology in the more than 20.000 unclassified patients of the ERNs. For the first time in Europe we will also implement a novel brokerage structure connecting clinicians, gene discoverer and basic researcher to quickly verify novel genes and disease mechanisms.

Koordinator

Eberhard Karls Universität Tübingen

Laufzeit

01.01.2018 - 31.12.2022

Website

Partner

Prof. Dr. Joachim L. Schultze
DZNE / LIMES-Institut der Universität Bonn
Gemeinsame epigenomische Plattform
Venusberg-Campus 1
Gebäude 99
53127 Bonn

Abstract

"The SYSCID consortium aims to develop a systems medicine approach for disease prediction in CID. We will focus on three major CID indications with distinct characteristics, yet a large overlap of their molecular risk map: inflammatory bowel disease, systemic lupus erythematodes and rheumatoid arthritis. We have joined 15 partners from major cohorts and initiatives in Europe (e.g.IHEC, ICGC, TwinsUK and Meta-HIT) to investigate human data sets on three major levels of resolution: whole blood signatures, signatures from purified immune cell types (with a focus on CD14 and CD4/CD8) and selected single cell level analyses. Principle data layers will comprise SNP variome, methylome, transcriptome and gut microbiome. SYSCID employs a dedicated data management infrastructure, strong algorithmic development groups (including an SME for exploitation of innovative software tools for data deconvolution) and will validate results in independent retrospective and prospective clinical cohorts.
Using this setup we will focus on three fundamental aims : (i) the identification of shared and unique ""core disease signatures” which are associated with the disease state and independent of temporal variation, (ii) the generation of ""predictive models of disease outcome""- builds on previous work that pathways/biomarkers for disease outcome are distinct from initial disease risk and may be shared across diseases to guide therapy decisions on an individual patient basis, (iii) ""reprogramming disease""- will identify and target temporally stable epigenetic alterations in macrophages and lymphocytes in epigenome editing approaches as biological validation and potential novel therapeutic tool .
Thus, SYSCID will foster the development of solid biomarkers and models as stratification in future long-term systems medicine clinical trials but also investigate new causative therapies by editing the epigenome code in specific immune cells, e.g. to alleviate macrophage polarization defects."

Koordinator 

Christian-Albrechts-Universität zu Kiel

Laufzeit 

01.01.2017 - 30.09.2022

Website27


Marie-Curie

Informieren Sie sich über die Marie-Curie-Verbundprojekte wie International Training Networks (ITN) und Research and Innovation Staff Exchange (RISE), an denen Wissenschaftler*innen der Universität Bonn beteiligt sind.

INTEGRATA_logo_w.jpg
© INTEGRATA

ITN-Projekte der Universität Bonn

Partnerin

Dr. Melanie Braun
Institute of Crop Science and Resource Conservation
Division Soil Science
Nussallee 13
D-53115 Bonn

Abstract

Plastic is a vital material in our economy and daily lives. Unfortunately, it is associated with high levels of waste and leakage to the environment. For instance, plastic debris and especially microplastics (particles less than 5 mm in size) can be found in agricultural soils – from silage bags and greenhouse cover films to sewage sludge and compost. The EU-funded SOPLAS project will assemble a multidisciplinary team to study the nexus of plastic–agriculture–soil. It will also train a new generation of leading experts. The project aims to identify the plastic cycle within agricultural soil systems and support the development of environmental policies related to mitigating the impact of plastics. The findings will advance our knowledge about the sustainable use of plastics in European agriculture.

Koordinator

Universität Augsburg

Laufzeit

01.01.2021 - 31.12.2024

Partner

Prof. Dr. Johannes Oldenburg
Institut für Experimentelle Hämatologie und Transfusionsmedizin (IHT)
Venusberg-Campus 1
53127 Bonn

Abstract

The development of anti-drug antibodies is the major complication of treatment with biotherapeutics. This is particularly true of patients with haemophilia A (HA) who develop neutralizing antibodies to therapeutic factor VIII (FVIII) following replacement therapy with exogenous pro-coagulant FVIII. The onset of neutralizing antibodies to FVIII, referred to as FVIIIinhibitors, represents a major societal concern owing to the enormous cost associated to the clinical management ofinhibitor-positive patients, that exceeds 200,000€/patient/year. The EDUC8 program is a multidisciplinary training programwith exposure of the enrolled ESRs to a core common educational package and development of individual PhD researchprojects dedicated to decreasing the societal burden associated with the development of anti-FVIII antibodies in Europe. Thecore educational program includes exposure to basic science in the fields of immunology and hemostasis, to the most advanced “omic” technologies in order to anticipate tomorrow’s scientific discoveries, and to the importance of ethical considerations and public awareness in today’s research. A key component of the training program is provided by immersion of the ESRs in a clinical center for HA, which will provide them with a unique experience and foster the conception of novel and realistic therapeutic approaches. The ESRs will exploit the accumulated theoretic and practical experience in an entrepreneurship training on key strategic, technical, financial and human resource issues required for the creation of startups. In a tribute to the concept of the fully developed mind coined by the French philosopher Michel de Montaigne on education, our ambition is to form a novel generation of scientists with deep scientific knowledge, multicultural exposure,
imagination, pragmatism and understanding of both the academic and private sectors. This will foster translational research in European on the immunogenicity of therapeutic proteins.

Koordinator

Institut National de la Sante et de la Recherche Medicale

Laufzeit

01.04.2020 - 31.03.2024

Website

Partner

Prof. Dr. Jens Lehmann
Institut für Informatik III
Endenicher Allee 19a
53115 Bonn

Abstract

With a rapidly increasing degree of integration among the European countries, a rising number of events, such as Paris shootings and Brexit, strongly impact the European community and the European digital economy across language and country borders. This development results in a vast amount of event-centric multilingual information available from different communities in the news, on the Web and in social media. Cross-lingual technologies to efficiently access, analyse and interact with this information are of utmost importance for various stakeholder groups across Europe, including digital humanities, memory institutions, publishers, media monitoring companies and journalists.

The Cleopatra ITN offers a unique interdisciplinary and intersectoral research and training programme addressing these challenges. The main objectives are to: 1) Facilitate advanced cross-lingual processing of event-centric textual and visual information on a large scale; 2) develop innovative methods for efficient and intuitive user access and interaction with multilingual information; 3) facilitate large-scale analytics of multilingual event-centric information and cross-cultural studies; 4) educate a group of top-level scientists with unique interdisciplinary and intersectoral expertise in multilingual information science who will be enabled to take leading roles in research and industry in the future; and 5) establish an interdisciplinary curriculum for cross-lingual information analytics.

The main outcomes of Cleopatra include: 1) novel methods for event-centric cross-lingual processing; 2) highly innovative user interaction paradigms for multilingual information; 3) open large-scale data sets and software components for a variety of EU languages; and 4) an interdisciplinary curriculum and educational materials. Overall, Cleopatra will contribute to the European digital economy in several application domains and strengthen the European position in multilingual information science.

Koordinator

Gottfried Wilhelm Leibniz Universität Hannover

Laufzeit

01.01.2019 - 30.06.2023

Website29

Partner

Prof. Dr. Bernd Weber
Zentrum für Wirtschafts- und Neurowissenschaften
Nachtigallenweg 86
53127 Bonn

Abstract

Recent breakthroughs in neuroeconomics are helping to understand how the human decision-making process takes place. Although latest advances have revealed that most of the brain processes that regulate our emotions, attitudes and decisions are beyond our consciousness (implicit processes), many companies are still making strategic decisions relying upon explicit measures such as questionnaires and focus groups. However, the consumer neuroscience market is rapidly growing and demands new knowledge, new skills and new approaches to adapt to the technological evolution of the sector but also for comprehending and communicating with consumers. These requests only find a partial match in existing doctoral programmes.

RHUMBO addresses this challenge by delivering an innovative multinational, multi-sectorial, and multidisciplinary research and training programme in cognitive neuroscience, transparently immersive experiences and artificial intelligence with a focus on neuro-business.

From the research point of view, RHUMBO will produce tools and models to predict human decision-making in business environments. RHUMBO will use mixed reality technologies (MRT) together with different biometric signals (fMRI, fNIRS, eye tracking, EEG, etc.), supported by artificial intelligence processing techniques, to examine consumer behavioural patterns during dynamic, complex and realistic situations for a deeper understanding of internal consumer psychological states.

With this purpose, RHUMBO’s partnership aggregates relevant scientific staff from the academic and corporate worlds which will be involved in a high-level personalised training programme that will guarantee ESRs and future PhD students outstanding Career Opportunities in the consumer behaviour sector and beyond. RHUMBO will disseminate results to a wide spectrum of stakeholders, create awareness in the general public about neuroscience and encourage neuroscience vocational careers among young students.

Koordinator

Universitat Politechnica de Valencia

Laufzeit

01.11.2018 - 31.10.2022

Website 

Partner

PD Dr. Georg Feldmann
Medizinische Klinik und Poliklinik III
Sigmund-Freud-Str. 25
53127 Bonn

Abstract

Deregulated nicotinamide adenine dinucleotide (NAD) biosynthesis and signaling underlies many aspects of carcinogenesis. NAD biosynthetic enzymes, such as nicotinamide phosphoribosyltransferase (NAMPT) and nicotinic acid phosphoribosyltransferase (NAPRT), are commonly upregulated in cancer cells, where they fuel increased metabolic demands and downstream enzymes involved in DNA repair and in the promotion of cell growth, cell motility, de-differentiation and immune escape. In addition, NAD-producing enzymes, such as NAMPT, moonlight in the extracellular space, exerting strongly pro-oncogenic, autocrine and paracrine effects. Many of these roles of NAD-producing and NAD-utilizing enzymes appear to be shared between solid and haematological cancers. Thus, agents targeting NAD production or signaling are expected to have broad applicability. INTEGRATA will: 1. develop new NAD biosynthesis and NAD/nucleotide signaling inhibitors; 2. assess pharmacology and toxicity of the new therapeutics in preclinical models; 3. achieve the proof-of-concept of activity of the newly generated agents in relevant in vivo cancer models. INTEGRATA will train 14 PhD students in an overarching, interdisciplinary training programme that will include training-by-research, joint courses of technical, scientific, and transferrable skills, active participation to public scientific events, and an intense intersectoral networking exchange plan. The INTEGRATA Consortium encompasses academic institutions, research centres, and SMEs/biotech pharma, all with proven experience in higher education and training, and geared with state-of-the-art scientific and technical expertise and infrastructures.

Koordinator

Universita Degli Studi DI Genova

Laufzeit 

01.11.2018 - 31.10.2022

Website29

Partner

Prof. Dr. Seven Wehner
Klinik- und Poliklinik für Allgemein-, Viszeral-, Thorax- und Gefäßchirurgie
Venusberg-Campus 1
53127 Bonn

Abstract

The interplay between nutrition, gut microbiota, and its large numberof metabolic and immune mediators plays an essential role in the development of gut immune homeostasis in early life. This interaction needs to be better understood because a disturbed immune function in the neonatal period is harmful for neonatal survival and enhances the risk of chronic inflammatory disease later in life. In particular, preterm infants have an immature gut and an associated intestinal state of dysbiosis, which limits the efficacy of nutritional interventions to 1) support early life nutrition, 2) prevent sepsis and conditions such as necrotizing enterocolitis and intestinal failure, and 3) reduce the risk of chronic inflammatory diseases mediated by the gut. A major barrier to elucidating the critical nutritional-host-microbiome interactions and reducing neonatal mortality is the lack of expertise in this rapidly emerging area of metabolomics. We therefore proposes a multidisciplinary approach making use of a large-scale pre-existing clinical cohort of neonates, and state of the art analytical and bio-informatics tools. GROWTH is an Innovative Training Network focused on European Industrial Doctorates that aims to train young business-oriented researchers in developing pathological insights, biomarker diagnostics and personalized nutritional interventions for intestinal failure in neonates and preterm infants. As a multidisciplinary consortium that will involve the participation of 7 non-academic and 5 academic partners in the life sciences field and will attempt shortening the path from basic research to clinical applications.

Koordinator

DSCN Reseach B.V.

Laufzeit

01.06.2019 - 30.11.2023

Website31

Partner

Prof. Dr. Dr. Helga Sauerwein
Institut für Tierwissenschaften
Katzenburgweg 7 - 9
53115 Bonn

Abstract

The European “Joint Doctorate in Molecular Animal Nutrition” – MANNA – includes 6 universities, 9 private companies and 3 public research institutes from 8 European countries. The goal is to:
1) develop an Elite European School to train early stage researchers (ESR) in OMIC technologies applied to animal nutrition and in essential scientific, entrepreneurial and management skills;
2) evaluate the influence of innovative feed additives on animal production;
3) deliver double doctoral (PhD) degrees in a multidisciplinary and multi-sectoral network to develop a generation of internationally equipped scientists for the global workplace.
The objectives will be achieved by co-supervising each of 11 ESRs with two Beneficiary Universities and a non-academic participant. They will work on integrated innovative research projects, designed to investigate the effects of anti-oxidants, microRNA, exosomes, methionine, lipids and plant derived anti-inflammatories in livestock diets on growth, intestinal health and systemic metabolism which will be assessed by integrating transcriptomic, microbiomic, proteomic and metabolomic approaches in both in vivo and in vitro models. The results will go into informatic platforms to build analytic systems based on IBM-Watson cognitive computing. Secondments will enhance the research programmes of all ESR being based in industry and non-academic research institutes, whose field of activity include animal nutrition, veterinary diagnostic and clinical research, bioinformatics and professional communication in the agro-food sector. All will contribute to training by including ESR in their working team, and providing lectures and training sessions in Summer Schools and workshops which will reinforce the graduate programmes of each University. The joint governance structure of MANNA will manage the recruitment, supervision and assessment processes across the network and will become embedded in the future post graduate education of each University.

Koordinator

University of Glasgow

Laufzeit

01.06.2018 - 30.11.2022

Website32

RISE-Projekte der Universität Bonn

Partner

Prof. Dr. Günter Mayer
University of Bonn
Life & Medical Sciences Institute (LIMES)
Chemical Biology
Gerhard-Domagk-Straße 1
53121 Bonn

Abstract

Non-codingRNAs (ncRNAs) represent a large class of molecules that in concert regulate the expression of genes involved in the key pathways governing cancer development and progression. They represent ideal targets for personalized cancer therapies and if appropriately designed they can provide specific, non-toxic and effective therapeutic tools. The identification of novel therapeutic ncRNAs and the design of their appropriate formulation is a key aspect for their clinical applicability. RISE- cONCReTE aims to form an international and inter-sectoral network of organizations working on a joint research programme on the development of a safe ncRNA-based drug. RISE- cONCReTE teams up experts in the fields of Molecular Oncology, Epigenetics, Signal transduction, Animal models, Therapeutic delivery and Imaging, business, and education. The participants will exchange skills, knowledge and staff members that will be exposed to synergetic and complementary research environments. RISE- cONCReTE will undertake an integrated approach to reveal novels functional links between ncRNAs and oncogenic pathways. We will: a) characterize novel classes of tumor-associated ncRNAs; b) investigate the impact of ncRNAs on key aspects of tumor cell biology; c) develop cargoes (e.g. aptamers) for delivering therapeutic ncRNA derivatives into specific cancer cell types. By using innovative in vivo imaging tools, we will monitor the accumulation of target ncRNAs in cancer cells and evaluate their biological efficacy in inhibiting the growth and spreading of malignant tumors. The resulting approaches will provide stable and effective tools thus potentially improving the quality of life (QOL) of the cancer patients. Further, the joint research and training programme of RISE- cONCReTE will be performed in academic institutions and SME to provide a unique interdisciplinary platform for scientists with a significant contribution to EU competitiveness.

Laufzeit 

01.05.2020 - 30.04.2024

Website

Partnerin

Institut für Tierwissenschaften
Katzenburgweg 7 - 9
53115 Bonn

Abstract

The ability of national and international agencies to cope effectively with large-scale natural disasters is becoming more and more important. The United Nations Office for the Co-ordination of Humanitarian Affairs (OCHA, 2016) reports an increase in the frequency and impact of large-scale natural disasters in both the developed and developing world. Recent extreme events such as Storm Jonas (2016, USA), the earthquake and tsunami in Tōhoku (2011) and New Zealand (2016) have demonstrated the need for a rapid and effective external response to complex events, and the impact on the human population when this is delayed or inadequate. The Emergency Resources Supply Chain (ERSC) has a crucial role in promoting the effective application of disaster management, and differs from conventional supply chains in several ways. The unique characteristics of ERSC include: a) having to analyse all the demands in a very short period of time, using limited resources. b) having to be designed, constructed and maintained in order to support continuous and smooth materials and information flows, and c) having to include a set of diverse plans, resources, authorities, agencies, and their associated human resources.
A recent review has emphasized the relative scarcity of the literature on these topics, and research on ERSC vulnerability/ resilience is particularly underdeveloped. This project will develop a decision support framework to capture and minimize the vulnerability of ERSC in large-scale natural disasters, and increase resilience when impacted by adverse circumstances. This joint collaboration will a) explore and understand the nature of ERSC vulnerability and the root causes of failures, and b) develop and enhance a framework for identifying the vulnerable components and evaluating the performance. The research results will facilitate the analysis of the relationship between ERSC vulnerability and capacity, and therefore increase resilience to adverse circumstance.

Laufzeit

01.05.2019 - 31.01.2024


Ihre Ansprechpersonen im Forschungsdezernat

Avatar Pag

Dr. Ulrike Pag

Dipl. Biol.

0.006

Poppelsdorfer Allee 47

53115 Bonn

+49 228 73-3073

Avatar Eder

Dorothee Eder

Dipl. Geogr.

0.007

Poppelsdorfer Allee 47

53115 Bonn

+49 228 73-7346

Sie interessieren sich für eine Antragstellung in Horizon Europe?

Informieren Sie sich über das Service-Angebot im Forschungsdezernat.

Wird geladen